Using sound to stimulate certain brain waves has the potential to help those with dementia or cognitive decline sleep better, reveals a new study. Sleep…
Seventy-nine-year-old Genevieve Lane volunteered to take the Alzheimer’s drug Leqembi in a clinical trial because she was forgetting words and misplacing her keys.
Alzheimer’s disease (AD) remains one of the most challenging and prevalent neurodegenerative disorders, affecting millions worldwide. In two recent studies, researchers led by Prof. Lucía…
In a study of 991 adults, scientists at DZNE have shown that the most common forms of frontotemporal dementia (FTD) as well as the neurological…
A new study from Duke-NUS Medical School has highlighted the widespread use of physical restraints among caregivers of older adults with advanced dementia living at…
It’s welcome news for Alzheimer’s patients and their families: A Food and Drug Administration advisory panel unanimously recommended approval for Eli Lilly & Co.’s treatment…
A new study by investigators from Mass General Brigham suggests that whether a person inherits risk of Alzheimer’s disease from their mother or father influences…
Neurodegenerative diseases (NDDs), which have no known cures and elusive causes, result in irreversible damage to the brain and nervous system. Research into these diseases…
Each time the heart beats, it pumps blood through the brain vessels, causing them to expand slightly and then relax, much like the rise and…
Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are two devastating neurodegenerative diseases. Scientists have long suspected a protein called FUS might play a role,…